• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUPPORT-AF III研究:通过向医疗服务提供者提示房颤口服抗凝治疗来支持使用华法林。

SUPPORT-AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF.

作者信息

Sadiq Hammad, Hoque Laboni, Shi Qiming, Manning Gordon, Crawford Sybil, McManus David, Kapoor Alok

机构信息

University of Massachusetts Medical School, Worcester, MA, USA.

UMass Memorial Health Care, Worcester, MA, USA.

出版信息

J Thromb Thrombolysis. 2021 Oct;52(3):808-816. doi: 10.1007/s11239-021-02420-8. Epub 2021 Mar 10.

DOI:10.1007/s11239-021-02420-8
PMID:33694097
Abstract

Only half of atrial fibrillation (AF) patients with elevated stroke risk receive anticoagulation (AC). Electronic health record (EHR) alerts have the potential to close the gap. We designed an outpatient EHR alert (linked to an order set for ordering AC, labs, and specialty referrals) that fired when cardiology and primary care providers (PCPs) saw AF patients not on AC. We assigned all untreated patients seen by cardiology providers and PCPs in the 8 months before and after the alert launch to pre- and post-launch intervention cohorts, respectively. Untreated AF patients seeing other types of providers became controls. We then compared the difference in AC starts between intervention and control patients post-launch to the same difference prelaunch (adjusting for covariates). We measured alert responsiveness as how often patients had at least one encounter with a provider, who interacted with the alert. The adjusted percentage of AC starts for the prelaunch cohort was 20% for intervention patients and 17% for controls (difference = 3%); post-launch, the percentage was 13% for both post-launch intervention and controls (difference = 0%). The difference in difference was - 3% (p value 0.63). For half of patients, at least one provider was responsive to our alert. Reasons for no AC commonly included relative contraindications (e.g. fall, gastrointestinal bleed). Our alert did not increase AC starts but responsiveness to it was high. Increasing AC starts will likely require education surrounding relative contraindications.

摘要

仅有一半中风风险升高的心房颤动(AF)患者接受了抗凝治疗(AC)。电子健康记录(EHR)警报有可能缩小这一差距。我们设计了一种门诊EHR警报(与用于订购AC、实验室检查和专科转诊的医嘱集相关联),当心脏病专家和初级保健提供者(PCP)查看未接受AC治疗的AF患者时触发该警报。我们将警报发布前后8个月内心脏病专家和PCP诊治的所有未治疗患者分别分配到发布前和发布后的干预队列。诊治其他类型提供者的未治疗AF患者成为对照。然后,我们将发布后干预组和对照组患者AC启动率的差异与发布前的相同差异进行比较(对协变量进行调整)。我们将警报响应性衡量为患者与触发警报的提供者至少有一次接触的频率。发布前队列中,干预组患者AC启动的调整百分比为20%,对照组为17%(差异=3%);发布后,发布后干预组和对照组的百分比均为13%(差异=0%)。差异的差异为-3%(p值0.63)。对于一半的患者,至少有一名提供者对我们的警报有响应。未进行AC治疗的常见原因包括相对禁忌症(如跌倒、胃肠道出血)。我们的警报并未增加AC的启动率,但对其的响应性较高。提高AC的启动率可能需要围绕相对禁忌症开展教育。

相似文献

1
SUPPORT-AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF.SUPPORT-AF III研究:通过向医疗服务提供者提示房颤口服抗凝治疗来支持使用华法林。
J Thromb Thrombolysis. 2021 Oct;52(3):808-816. doi: 10.1007/s11239-021-02420-8. Epub 2021 Mar 10.
2
SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.SUPPORT-AF:试点多方面、基于电子病历的干预措施以改善抗凝药物处方
J Am Heart Assoc. 2018 Sep 4;7(17):e009946. doi: 10.1161/JAHA.118.009946.
3
SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.SUPPORT-AF II:通过心房颤动口服抗凝治疗的医疗服务提供者概况分析来支持抗凝剂的使用:一项关于电子概况分析和信息传递联合学术指导的群组随机研究,用于指导医疗服务提供者对心房颤动患者进行抗凝决策。
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005871. doi: 10.1161/CIRCOUTCOMES.119.005871. Epub 2020 Feb 17.
4
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol.SUPPORT-AF IV:通过向医疗服务提供者提示房颤口服抗凝治疗来支持AC的使用——房颤临床试验研究方案
Cardiovasc Digit Health J. 2021 Jul 17;2(4):222-230. doi: 10.1016/j.cvdhj.2021.06.001. eCollection 2021 Aug.
5
Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study.使用中风和出血风险计算器的信心、对抗凝药物的了解以及在具有挑战性的情况下开具抗凝药物的舒适度的调查:SUPPORT-AF II 研究。
J Thromb Thrombolysis. 2019 Nov;48(4):629-637. doi: 10.1007/s11239-019-01950-6.
6
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.医疗机构类型、抗凝药物处方模式与房颤患者的卒中风险
J Am Heart Assoc. 2018 Mar 10;7(6):e007943. doi: 10.1161/JAHA.117.007943.
7
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.美国社区实践中提供者专业特长与心房颤动治疗策略:ORBIT-AF 注册研究结果。
J Am Heart Assoc. 2013 Jul 18;2(4):e000110. doi: 10.1161/JAHA.113.000110.
8
Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.医疗机构专科、抗凝治疗与合并癌症的房颤患者的卒中风险
J Am Coll Cardiol. 2018 Oct 16;72(16):1913-1922. doi: 10.1016/j.jacc.2018.07.077.
9
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.在初级保健与心血管专业管理新发心房颤动的抗凝预防方面的差异和趋势:回顾性评估和房颤治疗评估(TREAT-AF)研究。
Am Heart J. 2013 Jan;165(1):93-101.e1. doi: 10.1016/j.ahj.2012.10.010. Epub 2012 Nov 20.
10
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients.有高出血风险的患者和计算机决策支持在心房颤动卒中预防中的应用:AF-ALERT 子研究:Piazza:高出血风险 AF 患者的结局。
J Thromb Thrombolysis. 2021 Jul;52(1):281-290. doi: 10.1007/s11239-020-02296-0. Epub 2020 Sep 30.

引用本文的文献

1
Comparing the Efficacy of Targeted and Blast Portal Messaging in Message Opening Rate and Anticoagulation Initiation in Patients With Atrial Fibrillation in the Preventing Preventable Strokes Study II: Prospective Cohort Study.在预防可预防性卒中研究II:前瞻性队列研究中,比较靶向和群发门户消息对房颤患者消息打开率和抗凝启动的疗效。
JMIR Cardio. 2024 Jan 24;8:e49590. doi: 10.2196/49590.
2
Impact of a pharmacist intervention on DOAC knowledge and satisfaction in ambulatory patients.药师干预对门诊患者 DOAC 知识和满意度的影响。
J Thromb Thrombolysis. 2023 Feb;55(2):346-354. doi: 10.1007/s11239-022-02743-0. Epub 2022 Dec 12.
3

本文引用的文献

1
SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.SUPPORT-AF II:通过心房颤动口服抗凝治疗的医疗服务提供者概况分析来支持抗凝剂的使用:一项关于电子概况分析和信息传递联合学术指导的群组随机研究,用于指导医疗服务提供者对心房颤动患者进行抗凝决策。
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005871. doi: 10.1161/CIRCOUTCOMES.119.005871. Epub 2020 Feb 17.
2
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).针对未接受抗凝治疗的高危住院房颤患者的基于警报的计算机化决策支持:一项随机对照试验(AF-ALERT)
Eur Heart J. 2020 Mar 7;41(10):1086-1096. doi: 10.1093/eurheartj/ehz385.
3
Preventing preventable strokes: A study protocol to push guideline-driven atrial fibrillation patient education via patient portal.
预防可预防的中风:一项通过患者门户网站推动基于指南的心房颤动患者教育的研究方案。
Cardiovasc Digit Health J. 2022 Aug 3;3(5):241-246. doi: 10.1016/j.cvdhj.2022.07.068. eCollection 2022 Oct.
4
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol.SUPPORT-AF IV:通过向医疗服务提供者提示房颤口服抗凝治疗来支持AC的使用——房颤临床试验研究方案
Cardiovasc Digit Health J. 2021 Jul 17;2(4):222-230. doi: 10.1016/j.cvdhj.2021.06.001. eCollection 2021 Aug.
SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.SUPPORT-AF:试点多方面、基于电子病历的干预措施以改善抗凝药物处方
J Am Heart Assoc. 2018 Sep 4;7(17):e009946. doi: 10.1161/JAHA.118.009946.
4
A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study).一种改善房颤卒中风险患者抗凝治疗依从性的临床决策支持工具:一项在瑞典初级保健环境中的集群随机试验(CDS-AF 研究)。
PLoS Med. 2018 Mar 13;15(3):e1002528. doi: 10.1371/journal.pmed.1002528. eCollection 2018 Mar.
5
Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.促进抗凝治疗并降低中风风险的自动化软件系统:整群随机对照试验
Stroke. 2017 Mar;48(3):787-790. doi: 10.1161/STROKEAHA.116.015468. Epub 2017 Jan 24.
6
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
7
Massachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism: A Cost-Effectiveness Analysis.马萨诸塞州医疗改革成本更低,对静脉血栓栓塞症 uninsured 个体更有效:一项成本效益分析。 (注:这里“uninsured”原词有误,推测可能是“insured”,若为“insured”则译为“参保的” )
Med Care. 2016 May;54(5):474-82. doi: 10.1097/MLR.0000000000000506.
8
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组及心律学会的报告
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28.
9
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.心房颤动抗凝治疗的风险与获益:来自心房颤动更明智治疗结局登记研究(ORBIT - AF)登记处的见解
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):461-9. doi: 10.1161/CIRCOUTCOMES.113.000127. Epub 2013 Jun 11.
10
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.采用新型基于风险因素的方法对房颤患者的卒中与血栓栓塞风险进行临床分层的研究:房颤的欧洲心脏调查。
Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.